Check Novabay Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$10.2M
EPS (TTM)
0Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0.76
Industry PE ratio
0P/B Ratio
0.7609
PEG Ratio
0EBITDA
-5.6M
Revenue (TTM)
9.8M
Profit Margin
33.98%
Return On Equity TTM
-413.78%
Track how Novabay Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Novabay Pharmaceuticals Inc in the last 5 years
Lowest (0.00x)
September 18, 2025
Industry (0.00x)
September 18, 2025
Today (0.76x)
September 18, 2025
Highest (-0.29x)
March 31, 2025
Today’s Price to Earnings Ratio: 0.76x
Compare market cap, revenue, PE, and other key metrics of Novabay Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $10.2M | -99.81% | 0.76 | 33.98% | |
BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Novabay Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Novabay Pharmaceuticals Inc investment value today
Current value as on today
₹3,97,110
Returns
₹2,97,110
(+297.11%)
Returns from Novabay Pharmaceuticals Inc Stock
₹2,92,157 (+292.16%)
Dollar Returns*
₹4,953 (+4.95%)
Based on 6 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 6 analysts, 83.33% of analysts recommend a 'BUY' rating for Novabay Pharmaceuticals Inc. Average target price of $0.85
Get share price movements and forecasts by analysts on Novabay Pharmaceuticals Inc.
What analysts predicted
-135.29%DOWNSIDE
Target Price
$0.85
Current Price
$2
Analyzed by
6 Analysts
Target
$0.85
Novabay Pharmaceuticals Inc target price $0.85, a slight downside of -135.29% compared to current price of $2. According to 6 analysts rating.
Investment in Novabay Pharmaceuticals Inc Shares on INDmoney has grown by 7171.42% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:7171.42% versus previous 30 day period
Search interest for Novabay Pharmaceuticals Inc Stock has increased by 4105% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:4105% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, NBY has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
In the last 1 month, NBY stock has moved up by 180.9%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 210.5%
Revenue Fall
Revenue is down for the last 3 quarters, 2.44M → 2.30M (in $), with an average decrease of 2.7% per quarter
Profit Down
Netprofit is down for the last 2 quarters, 7.67M → -1.92M (in $), with an average decrease of 125.1% per quarter
Organisation | Novabay Pharmaceuticals Inc |
Headquarters | 2000 Powell Street, Emeryville, CA, United States, 94608 |
Industry | Health Technology |
CEO | Mr. Justin M. Hall Esq., J.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Justin M. Hall Esq., J.D. | President, CEO, General Counsel, Chief Compliance Officer, Corporate Secretary & Director |
Mr. Tommy Law | Controller, Interim CFO & Treasurer |
Novabay Pharmaceuticals Inc share price today is $2 as on . Novabay Pharmaceuticals Inc share today touched a day high of $2.1 and a low of $1.78.
Novabay Pharmaceuticals Inc share touched a 52 week high of $4.44 on and a 52 week low of $0.46 on . Novabay Pharmaceuticals Inc stock price today i.e. is trending at $2,which is 54.95% down from its 52 week high and 334.78% up from its 52 week low.
Novabay Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Novabay Pharmaceuticals Inc (NBY) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Novabay Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Novabay Pharmaceuticals Inc share’s latest price of $2 as on September 18, 2025 at 7:43 pm IST, you will get 5.0000 shares of Novabay Pharmaceuticals Inc. Learn more about
fractional shares .
Novabay Pharmaceuticals Inc stock has given -99.81% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?